
Dante Labs is a leading global genomics and precision medicine company dedicated to advancing scientific innovation in healthcare. Their core business revolves around Whole Genome Sequencing (WGS) for diagnostics and longevity, supported by a proprietary AI and machine learning platform for genomic data analysis. They aim to improve human well-being and save lives by making advanced genetics accessible to everyone, particularly aiding rare disease patients in ending their diagnostic odysseys. The company leverages 30X whole genome sequencing for unparalleled accuracy, delivering detailed, easy-to-understand reports and offering access to genetic and medical experts for interpretation and support. Dante Labs has demonstrated significant revenue growth, with a reported +258.32% increase from 2019 to 2022.

Dante Labs is a leading global genomics and precision medicine company dedicated to advancing scientific innovation in healthcare. Their core business revolves around Whole Genome Sequencing (WGS) for diagnostics and longevity, supported by a proprietary AI and machine learning platform for genomic data analysis. They aim to improve human well-being and save lives by making advanced genetics accessible to everyone, particularly aiding rare disease patients in ending their diagnostic odysseys. The company leverages 30X whole genome sequencing for unparalleled accuracy, delivering detailed, easy-to-understand reports and offering access to genetic and medical experts for interpretation and support. Dante Labs has demonstrated significant revenue growth, with a reported +258.32% increase from 2019 to 2022.